Articles with public access mandates - Roy L SoizaLearn more
Available somewhere: 53
Dexamethasone in hospitalized patients with Covid-19
RECOVERY Collaborative Group
New England Journal of Medicine 384 (8), 693-704, 2021
Mandates: Bill & Melinda Gates Foundation, Cancer Research UK, UK Medical Research …
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...
The Lancet 397 (10285), 1637-1645, 2021
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, British …
Effect of hydroxychloroquine in hospitalized patients with Covid-19
RECOVERY Collaborative Group
New England Journal of Medicine, 2020
Mandates: Bill & Melinda Gates Foundation, UK Medical Research Council, National …
Safety and efficacy of NVX-CoV2373 Covid-19 vaccine
PT Heath, EP Galiza, DN Baxter, M Boffito, D Browne, F Burns, ...
New England Journal of Medicine 385 (13), 1172-1183, 2021
Mandates: UK Medical Research Council, National Institute for Health Research, UK
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RC Group
Lancet 396, 1345-1352, 2020
Mandates: Bill & Melinda Gates Foundation, Department of International Development, UK …
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
RC Group
Lancet 397 (10289), 2049-2059, 2021
Mandates: Bill & Melinda Gates Foundation, British Heart Foundation, Cancer Research …
Efficacy and safety of COVID-19 vaccines in older people
RL Soiza, C Scicluna, EC Thomson
Age and ageing 50 (2), 279-283, 2021
Mandates: UK Medical Research Council
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RC Group
Lancet (London, England) 397 (10274), 605, 2021
Mandates: Bill & Melinda Gates Foundation, British Heart Foundation, Cancer Research …
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RC Group
Lancet 399 (10325), 665-676, 2022
Mandates: Bill & Melinda Gates Foundation, British Heart Foundation, UK Medical …
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial
PW Horby, G Pessoa-Amorim, L Peto, CE Brightling, R Sarkar, K Thomas, ...
Medrxiv, 2021
Mandates: Bill & Melinda Gates Foundation, UK Medical Research Council, National …
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
RC Group
Lancet 400 (10349), 359-368, 2022
Mandates: Bill & Melinda Gates Foundation, British Heart Foundation, UK Medical …
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 399 (10320), 143, 2022
Mandates: Bill & Melinda Gates Foundation, British Heart Foundation, UK Medical …
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 399 (10325), 665, 2022
Mandates: Bill & Melinda Gates Foundation, British Heart Foundation, UK Medical …
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
J Chalmers, H Abo-Leyah, H Loftus, M Spears, ...
Lancet 397 (10285), 1637-1645, 2021
Mandates: Bill & Melinda Gates Foundation, UK Medical Research Council, National …
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
The Lancet Respiratory Medicine 9 (12), 1419-1426, 2021
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, Cancer …
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer …
S Toback, E Galiza, C Cosgrove, J Galloway, AL Goodman, PA Swift, ...
The Lancet Respiratory Medicine 10 (2), 167-179, 2022
Mandates: UK Medical Research Council, National Institute for Health Research, UK …
Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome
M Taylor-Rowan, S Edwards, AH Noel-Storr, J McCleery, PK Myint, ...
Cochrane Database of Systematic Reviews, 2021
Mandates: Dunhill Medical Trust, UK, National Institute for Health Research, UK
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open …
RECOVERY Collaborative Group
Lancet (London, England) 401 (10387), 1499, 2023
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, British …
Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised …
BMC medicine 18, 1-16, 2020
Mandates: Chief Scientist Office, Scottish Executive, National Institute for Health …
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
PW Horby, G Pessoa-Amorim, N Staplin, JR Emberson, M Campbell, ...
The Lancet 399 (10320), 143-151, 2021
Mandates: Bill & Melinda Gates Foundation, British Heart Foundation, UK Medical …
Publication and funding information is determined automatically by a computer program